Prioritizing variants in complete Hereditary Breast and Ovarian Cancer (HBOC) genes in patients lacking known BRCA mutations
BRCA1 and BRCA2 deleterious mutations in high risk families from Tuscany
Germline BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance associated with breastiovarian cancer: a report from North India - Document - Gale Academic OneFile
BRCA1 and BRCA2 Missense Variants of High and Low Clinical Significance Influence Lymphoblastoid Cell Line Post-Irradiation Gene Expression
Germline BRCA1 and BRCA2 deleterious mutations and variants of unknown
Evaluation of unclassified variants in the breast cancer susceptibility genes BRCA1 and BRCA2using five methods: results from a population-based study of young breast cancer patients, Breast Cancer Research
Understanding and predicting the functional consequences of missense mutations in BRCA1 and BRCA2
Computational Biology of BRCA2 in Male Breast Cancer, through Prediction of Probable nsSNPs, and Hit Identification
Cancer Genetics Risk Assessment and Counseling (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf
Analysis of missense variants in the human genome reveals widespread gene-specific clustering and improves prediction of pathogenicity - ScienceDirect
Pan-cancer atlas of somatic core and linker histone mutations
List of the most common BRCA mutations and their recurrence in the CRO